Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Urologie (Heidelberg, Germany)
|
December 21, 2023
[Overall survival and cancer-specific mortality in patients with very high-risk non-muscle-invasive bladder cancer (NMIBC) : Retrospective analysis of a US American single-center cohort]
Henning Bahlburg, Florian Roghmann
Urologie (Heidelberg, Germany)
|
February 27, 2025
[Intravesical treatment of non-muscle-invasive bladder cancer]
Henning Bahlburg, Joachim Noldus, Florian Roghmann
The Journal of Urology
|
June 19, 2026
Reply by Authors
Henning Bahlburg, Vincent Bicocca, Trevor Levin, et al.
European Urology
|
November 30, 2024
Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?
Marie-Pier St-Laurent, Jussi Nikkola, Henning Bahlburg, et al.
BJUI Compass
|
June 15, 2026
The impact of high-grade complications on quality of life and psychosocial distress in the early period after radical cystectomy
Guido Müller, Henning Bahlburg, Mayumi Götte, et al.
Urologia Internationalis
|
December 16, 2024
Discrimination of T-Stage Using Tumor Weight and Size: A Potential Approach to Guide Perioperative Decision-Making in Patients with Bladder Cancer
Karl Tully, Henning Bahlburg, Moritz J Reike, et al.
Scandinavian Journal of Urology
|
January 19, 2023
Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections
Sebastian Berg, Karl Heinrich Tully, Vincent Hoffmann, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 10, 2023
Psychosocial distress and quality of life in patients after radical cystectomy - one year follow-up in 842 German patients
Henning Bahlburg, Tabea Hellmann, Karl Tully, et al.
Cancer Epidemiology
|
April 24, 2024
Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancer
Moritz J Reike, Henning Bahlburg, Mirco Brehmer, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 5, 2023
Return to work improves quality of life and reduces psychosocial distress after radical cystectomy: data from a contemporary series of 230 German patients
Henning Bahlburg, Moritz Reike, Karl Tully, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Urologie (Heidelberg, Germany)
|
December 21, 2023
[Overall survival and cancer-specific mortality in patients with very high-risk non-muscle-invasive bladder cancer (NMIBC) : Retrospective analysis of a US American single-center cohort]
Henning Bahlburg, Florian Roghmann
Urologie (Heidelberg, Germany)
|
February 27, 2025
[Intravesical treatment of non-muscle-invasive bladder cancer]
Henning Bahlburg, Joachim Noldus, Florian Roghmann
The Journal of Urology
|
June 19, 2026
Reply by Authors
Henning Bahlburg, Vincent Bicocca, Trevor Levin, et al.
European Urology
|
November 30, 2024
Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?
Marie-Pier St-Laurent, Jussi Nikkola, Henning Bahlburg, et al.
BJUI Compass
|
June 15, 2026
The impact of high-grade complications on quality of life and psychosocial distress in the early period after radical cystectomy
Guido Müller, Henning Bahlburg, Mayumi Götte, et al.
Urologia Internationalis
|
December 16, 2024
Discrimination of T-Stage Using Tumor Weight and Size: A Potential Approach to Guide Perioperative Decision-Making in Patients with Bladder Cancer
Karl Tully, Henning Bahlburg, Moritz J Reike, et al.
Scandinavian Journal of Urology
|
January 19, 2023
Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections
Sebastian Berg, Karl Heinrich Tully, Vincent Hoffmann, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 10, 2023
Psychosocial distress and quality of life in patients after radical cystectomy - one year follow-up in 842 German patients
Henning Bahlburg, Tabea Hellmann, Karl Tully, et al.
Cancer Epidemiology
|
April 24, 2024
Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancer
Moritz J Reike, Henning Bahlburg, Mirco Brehmer, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 5, 2023
Return to work improves quality of life and reduces psychosocial distress after radical cystectomy: data from a contemporary series of 230 German patients
Henning Bahlburg, Moritz Reike, Karl Tully, et al.
Page
of 3